MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Breast Cancer Treatment Studies
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,781 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,781 works in the cohort · of 4,299,418page 14 of 56

Labels cover 13 of 2,781 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,781 of 2,781 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Platinum-based chemotherapy in triple-negative advanced breast cancer
Cynthia Villarreal‐Garza, Daniel Khalaf, Nathaniel Bouganim, Mark Clemons, Omar Peña‐Curiel, Berenice Baez-Revueltas +7 more
2014· review· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
33
citations
affunlabeled
Biomarker data from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer.
Carsten Denkert, Chiara Lambertini, Peter A. Fasching, Katherine L. Pogue–Geile, Max S. Mano, Michael Untch +12 more
2020· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
32
citations
affunlabeled
Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
Robert J. Gray, Rosie Bradley, Jeremy Braybrooke, Christina Davies, H Pan, Richárd Pető +9 more
2018· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
32
citations
affno abstractunlabeled
Radiotherapy for breast cancer, the TARGIT-A trial
Joanne Haviland, Roger A’Hern, S.M. Bentzen, Timothy J. Whelan, Judith M. Bliss
2014· letter· en· The Lancet· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
31
citations
affunlabeled
Bilateral Mastectomy and Breast Cancer Mortality
Vasily Giannakeas, David W. Lim, Steven A. Narod
2024· letter· en· JAMA Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
31
citations
← previousnext →

How this was built: Screen · Findings · About